Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001213900-25-014538·Ernexa Therapeutics Inc.
Schedule 13G ownership disclosure
ETERNA THERAPEUTICS INC
Common stock, par value $0.005 per share · CUSIP: 114082209
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Nicholas Jason Singer
Shares: 2,565,001.00 · Class: 4.92%
- Purchase Capital LLC
Shares: 1,000,001.00 · Class: 1.95%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-25-014538
- Form type
- SCHEDULE 13G/A
- Filer
- Ernexa Therapeutics Inc.
- CIK
- CIK 748592
- Filed
- Feb 14, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership